Diabetes Flashcards

1
Q

What is the dominant anabolic hormone?

A

Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 main catabolic hormones?

A

Glucagon, catecholamines, cortisol, growth hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the definition of diabetes mellitus?

A

A reduction in insulin action sufficient to cause a level of hyperglycaemia that, over time, will result in diabetes specific, microvascular (capillary) pathology in eyes, kidneys and nerves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does Non-Diabetic Hyperglycaemia (NDH)/IGT increase risk of?

A

Macrovascular disease (CHD, CVD, PVD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is DM diagnosed?

A
  • Fasting Glucose (x2 or + symptoms) >/=7.0mmol/L
  • 2hr post glucose load (or random glucose) >/= 11.1mmol/L
  • HbA1c greater or equal to 48mmol/mol – diagnosed DM.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is IGT diagnosed? (3)

A
  • Fasting Gluc <7.0
  • 2h-post glucose load >7.8, <11.1
  • HbA1c 42-47 mmol/mol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the features of T1DM?

A

beta cell destruction, organ specific auto-immunity, mostly childhood onset, ketosis prone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the features of T2DM?

A

Insulin resistance + beta-cell dysfunction, Mostly adult onset, Ketosis resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a big modifiable risk factor for T2DM?

A

Obesity. Insulin resistance is closely linked to abdominal obesity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the risk factors for T2DM?

A

Modifiable - Diet composition, lack of exercise, overweight and obese

non-modifiable - FH, ethnicity, age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is diabetes insipidus?

A

Passage of large volumes (3L/day) of dilute urine due to impaired water resorption by kidney. This is because of reduced ADH secretion from the posterior pituitary (cranial DI) or impaired response of kidney to ADH (nephrogenic DI).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the signs and symptoms of hypercalcaemia?

A

Abdo pain, vomiting, constipation, polyuria, polydipsia, depression, anorexia, weight loss, tiredness, weakness, hypertension, confusion, pyrexia, renal stones, renal failure ectopic calcification, cardiac arrest (decresed QT interval).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What the symptoms of hyperglycaemia?

A

Thirst, polyuria, polyphagia, tiredness, weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What investigations are used to diagnose diabetes? urine + blood tests

A

Urine Testing - Glucose, Ketones, Protein

Blood Testing - Glucose, Ketones, Glycated haemoglobin/fructosamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is proteinuria a sign of?

A

Diabetic Nephropathy (Nephrotic Syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is involved in an annual care plan? (4)

A

Risk Factor Review, early detection of complications (eyes, kidneys, feet), patient and professional review of results, care planning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is involved in a baseline management plan? (3)

A

Explanation and discussion of disease, referral to structured education programmed (e.g. XPERT, DESMOND), baseline annual checks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How many checks should a person with diabetes have?

A

9/year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What does a baseline annual check consist of? (5)

A

Lipid check, Urine ACR, eGFR, Foot exam, refer to diabetic eye screening programme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the treatment goals in diabetes? (4)

A

minimise side effects, blood glucose near-normal as possible, CVD risk management, effective self management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the treatment for T1DM

A

Insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is foundation of T2DM management?

A

Lifestyle - particularly weight management diet and exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What drugs are used in T2DM?

A
  • Biguanide e.g. Metformin
  • Thiazolidinediones e.g. Pioglitazone
  • Sulphonylureas e.g Gliclazide, Glipizide
  • Meglitinides e.g. Nateglinide, Repaglinide
  • Incretin based therapy - DPP4 inhibitors (e.g. sitagliptin) & Incretins, GLP1 agonists e.g. (exenatide, liraglutide)
  • SGLT2 antagonists (Dapagliflozin, Canagliflozin, Empagliflozin)
24
Q

How often do you measure HbA1C levels in adults with T2DM?

A
  • 3–6-monthly intervals (tailored to individual needs), until the HbA1c is stable on unchanging therapy
  • 6-monthly intervals once the HbA1c level and blood glucose lowering therapy are stable
25
Q

What is the HbA1C target level for T2 diabetics on a single drug?

A

48mmol/mol (6.5%), or 53 mol/mol (7.0%) if on drug associated w/ hypoglycaemia

26
Q

How is a patient whose HbA1c levels are not adequately controlled by a single drug and rise to 58 mmol/mol (7.5%) or higher managed?

A
  • reinforce advice about diet, lifestyle and adherence to drug treatment and
  • support the person to aim for an HbA1c level of 53 mmol/mol (7.0%) and
  • intensify drug treatment.
27
Q

What is first line treatment of T2DM?

A

standard release metformin

28
Q

What is first intensification treatment?

A
  • metformin and a DPP‑4 inhibitor or
  • metformin and pioglitazone or
  • metformin and a sulfonylurea.
29
Q

What is second intensification treatment?

A
  • Triple therapy with: metformin, a DPP‑4 inhibitor and a sulfonylurea or metformin, pioglitazone and a sulfonylurea

OR

  • starting insulin-based treatment
30
Q

What are the DVLA regulations for diabetes?

A
  • Declare to DVLA if complication or on insulin therapy
  • Glucose Below <5mmol/L - not able to drive.
  • If feeling symptoms - turn off car, sit in passenger seat, treat hypoglycaemia. ‘Rule of 15’ - take 15g of glucose, re-check in 15 mins.
  • Refrain from driving until at least 45 mins after treatment of hypoglycaemia
31
Q

What causes visual loss in diabetic eye disease?

A

Capillary leakage causes retinal haemorrhage and oedema. Capillary occlusion causes retinal ischaemia (cotton wool spots) which causes angiogenesis. The new vessels can causes a vitral bleed or fibrosis, which can lead to traction retinal detachment.

32
Q

How is diabetic nephropathy prevented?

A

anti-hypertensive treatment, BG control

33
Q

What causes a neuropathic foot ulcer?

A

Loss of protective sensation and abnormal foot function.  Foot ulceration occurs as a result of trauma (often trivial) in the presence of neuropathy and/or peripheral vascular disease with infection occurring as a secondary phenomenon following disruption of the protective epidermis.

34
Q

What is charcot’s foot?

A

It is a progressive condition affecting the bones and joints of the foot; it is characterised by early inflammation and then joint dislocation, subluxation, and pathological fractures of the foot of neuropathic patients, often resulting in debilitating deformity

35
Q

What is the link between diabetes and CVD?

A

Multi -vessel disease and atheromatous involvement of smaller calibre arteries is more common with hyperglycaemia

All hyperglycaemia is associated with increased risk of CAD, Stroke and total mortality

36
Q

How is type 1 diabetes confirmed?

A

Anti-GAD antibody test or islet cell antibodies

37
Q

Which diabetes medications cause an increased risk of hypoglycaemia?

A

Sulfonylurea, megatinides, insulin therapy

38
Q

What are precipitating factors of DKA?

A

Alcohol binge (interrupts gluconeogenesis), stress and infection, missing meals, missing insulin doses

39
Q

What causes DKA?

A

a severe insulin deficiency and increased catabolic hormones (glucagon, catecholamines, cortisol, GH). This leads to excess glucose, ketones (lipolysis) and impaired/saturated disposal

40
Q

What electrolytes are lost in DKA?

A

Na+ and K+ due to osmotic diuretic effect of glucose

41
Q

What causes K+ loss?

A

Osmotic diuresis, secondary hyperaldosteronism due to poor renal perfusion, increased H+ ions which displace K+

42
Q

What are the symptoms of DKA?

A

polyuria, polydipsia, weight loss, weakness, nausea, vomiting (ketosis + hyperglycaemic gastric stasis), leg cramps, blurred vision, abdominal pain

43
Q

What are the signs of DKA?

A

Dehydration (osmotic diuresis + vomiting), hypotension with warm peripheries (dehydration and vasodilation from acidosis), cold extremities, tachycardia, Kussmaul breathing, acetone on breath, hypothermia, confusion, drowsiness, coma (severe hypotension – CV shock), hyperventilation (met acidosis), hypokalaemia

44
Q

What investigations are performed in suspected DKA?

A

Venous blood - gas, U&Es, bicarbonate
Urine/Blood - ketones
ECG
Infection Screen

45
Q

What ECG changes are seen hypokalaemia?

A

T wave inversion, U waves, increased P width, prolonged PR interval, depressed ST

46
Q

How is DKA managed?

A

ABCDE, fluid replacement, insulin, correction of hypokalaemia (0.9% NaCl + KCl 40 mmol/L), VTE prophylaxis

47
Q

How is Hyperglycaemic hyperosmolar state (HHS) characterised

A

Severe hyperglycaemia (>30mmol/L), hyperosmolality (serum osmolality > 320 mOsm/ kg), and dehydration in the absence of hyperketonaemia

48
Q

What can precipitate HHS?

A

infection, myocardial infarction, cerebrovascular events or drug therapy

49
Q

How is HHS managed?

A

Measure/calculate serum osmolality frequently, give fluid replacement with 0.9% NaCl (IV), Aim for positive fluid balance of 3-6L by 12 hours and replacement of remaining estimated loss over next 12 hours, correct osmolality, fluid, electrolyte and BG imbalances

50
Q

How is T1DM managed?

A

Education in self management (i.e. DAFNE programme), lifelong insulin treatment

51
Q

When is Continuous subcutaneous insulin (pump) infusion recommended?

A

Attempts to achieve target haemoglobin A1c (HbA1c) levels with multiple daily injections (MDIs) result in the person experiencing disabling hypoglycaemia or HbA1c levels have remained high (that is, at 8.5% [69 mmol/mol] or above) on MDI therapy

52
Q

What is the mode of action of Liraglutide?

A

GLP-1 agonist

53
Q

What are the side effects of liraglutide?

A

N and V due to delayed gastric emptying, early satiety, weight loss

54
Q

Which anti-diabetic is contra-indicated in heart failure?

A

pioglitazone (Thiazolidinediones)

55
Q

What is impaired fasting glucose?

A

A fasting glucose greater than or equal to 6.1 but less than 7.0 mmol/l

56
Q

What is impaired glucose tolerance?

A

Impaired glucose tolerance (IGT) is defined as fasting plasma glucose less than 7.0 mmol/l and OGTT 2-hour value greater than or equal to 7.8 mmol/l but less than 11.1 mmol/l

57
Q

What are the main complications of sitagliptins? (3)

A

Acute pancreatitis, vasculitic rash that can progress to steven-johnson syndrome